A cytosine deaminase for programmable single-base RNA editing
Programmable RNA editing enables reversible recoding of RNA information for research and disease treatment. Previously, we developed a programmable adenosine-to-inosine (A-to-I) RNA editing approach by fusing catalytically inactivate RNA-targeting CRISPR-Cas13 (dCas13) with the adenine deaminase dom...
Main Authors: | Abudayyeh, Omar O., Gootenberg, Jonathan S, Franklin, Brian, Koob, Jeremy, Kellner, Max J., Ladha, Alim, Joung, Julia, Kirchgatterer, Paul, Cox, David B. T., Zhang, Feng |
---|---|
Other Authors: | McGovern Institute for Brain Research at MIT |
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS)
2020
|
Online Access: | https://hdl.handle.net/1721.1/126395 |
Similar Items
-
RNA editing with CRISPR-Cas13
by: Cox, David Benjamin Turitz, et al.
Published: (2020) -
Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA
by: Joung, Julia, et al.
Published: (2021) -
Engineering and optimising deaminase fusions for genome editing
by: Yang, Luhan, et al.
Published: (2017) -
SHERLOCK: nucleic acid detection with CRISPR nucleases
by: Kellner, Max J, et al.
Published: (2021) -
Characterization and Engineering of Transposons for Genome Editing
by: Ladha, Alim
Published: (2023)